Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study74

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study59

Views

Views
February 20250
March 202516
April 20252
May 20253
June 202514
July 202518
August 20256
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Brazil12
United States11
Hong Kong11
United Kingdom3
South Africa2
Argentina2
Spain1
Kenya1
 

Top cities views

Views
Hong Kong11
Southwark2
Belo Horizonte1
Bom Jesus de Goiás1
Brasília1
Canarana1
Cape Town1
Caruaru1
Chicago1
Cotia1